The magic pills, Bud and Yvonne

Interviewee: Yvonne Yvonne talks about the magic pills Bud took.

I always call them the magic pills, I think he started taking them on April the 26th of 99 and by May the 17th he was normal on his white blood count. Absolutely normal.

chronic myeloid leukemia,white blood count,magic pills,gleevec,romine,cml,yvonne,leukemia,bud

  • ID: 16105
  • Source: DNALC.DNAi

Related Content

15043. Bloodcount returns to normal with Gleevec, Bud and Yvonne

CML causes an increased production of white blood cells. Bud and Yvonne talk about the breakthrough that brought Bud's white blood cell count back to normal.

  • ID: 16105
  • Type: video
  • Source: DNAi

15712. Bud and Yvonne

Bud and Yvonne are delighted by Bud's recovery thanks to Gleevec

  • ID: 16105
  • Type: video
  • Source: DNAi

15042. The first day of clinical trials for Gleevec, Bud and Yvonne

Yvonne, Bud's wife, talks about the first day of the clinical trials in June of 1998.

  • ID: 16105
  • Type: video
  • Source: DNAi

15041. Getting the diagnosis of chronic myeloid leukemia, Bud

Bud recounts receiving the diagnosis that he had chronic myeloid leukemia.

  • ID: 16105
  • Type: video
  • Source: DNAi

1013. Diagnosis, Targeted therapies: Targeting activators, Sawyer 1

Professor Charles Sawyer explains that CML stands for chronic myeloid leukemia, which is a blood cancer and it is different from many cancers because it starts very slowly and patients when they're first diagnosed don't have many symptoms.

  • ID: 16105
  • Type: video
  • Source: IC

15994. The chronic myeloid leukemia (CML) mutation

View the animation to learn about the Philadelphia chromosome, the abnormal chromosome that causes chronic myeloid leukemia.

  • ID: 16105
  • Type: video
  • Source: DNAi

15525. How Gleevec works to alleviate symptoms of myeloid leukemia, 3D animation with basic narration

View the animation to find out how the drug Gleevec™ inhibits the molecular cause of chronic myeloid leukemia.

  • ID: 16105
  • Type: video
  • Source: DNAi

15714. Brian Druker

Brian Druker is a professor at Oregon Health Sciences University.

  • ID: 16105
  • Type: video
  • Source: DNAi

1012. Diagnosis, Targeted therapies: Targeting activators

In this section learn that tyrosine kinases are a family of activator proteins that trigger the cell signaling process leading to cell growth and division.

  • ID: 16105
  • Type: video
  • Source: IC

1014. Diagnosis, Targeted therapies: Targeting activators, Sawyer 2

Professor Charles Sawyer explains that Gleevec is a pill taken once a day and works remarkably well in all phases of CML.

  • ID: 16105
  • Type: video
  • Source: IC